Stereochemistry | MIXED |
Molecular Formula | C13H16Cl12O8 |
Molecular Weight | 725.697 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(OCC(COC(O)C(Cl)(Cl)Cl)(COC(O)C(Cl)(Cl)Cl)COC(O)C(Cl)(Cl)Cl)C(Cl)(Cl)Cl
InChI
InChIKey=OKACKALPXHBEMA-UHFFFAOYSA-N
InChI=1S/C13H16Cl12O8/c14-10(15,16)5(26)30-1-9(2-31-6(27)11(17,18)19,3-32-7(28)12(20,21)22)4-33-8(29)13(23,24)25/h5-8,26-29H,1-4H2
Molecular Formula | C13H16Cl12O8 |
Molecular Weight | 725.697 |
Charge | 0 |
Count |
MOL RATIO
1 MOL RATIO (average) |
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Petrichloral is the tetrahemiacetal pentaerythritol derivative of chloral. Animal trials and studies among institutionalized patients offer clinical evidence as to the therapeutic relationship between the drugs. Petrichloral exhibits a hypnotic and sedative action similar to chloral hydrate. It is better tolerated than the later drug.